Loring Wolcott & Coolidge Fiduciary Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.1K | Hold |
100
| – | – | ﹤0.01% | 484 |
|
|
2026
Q1 | $29.5K | Hold |
100
| – | – | ﹤0.01% | 457 |
|
|
2025
Q4 | $28.4K | Hold |
100
| – | – | ﹤0.01% | 454 |
|
|
2025
Q3 | $26.9K | Buy |
+100
| New | +$27.2K | ﹤0.01% | 464 |
|
|
2025
Q2 | – | Sell |
-7
| Closed | -$1.83K | – | 536 |
|
|
2025
Q1 | $1.83K | Hold |
7
| – | – | ﹤0.01% | 522 |
|
|
2024
Q4 | $1.66K | Sell |
7
-20
| -74% | -$4.6K | ﹤0.01% | 521 |
|
|
2024
Q3 | $6.2K | Buy |
+27
| New | +$5.59K | ﹤0.01% | 517 |
|
|
2023
Q2 | – | Sell |
-350
| Closed | -$67K | – | 637 |
|
|
2023
Q1 | $67K | Hold |
350
| – | – | ﹤0.01% | 379 |
|
|
2022
Q4 | $58.9K | Sell |
350
-3
| -0.8% | -$521 | ﹤0.01% | 387 |
|
|
2022
Q3 | $63K | Sell |
353
-30
| -8% | -$5.93K | ﹤0.01% | 385 |
|
|
2022
Q2 | $78K | Buy |
383
+3
| +0.8% | +$636 | ﹤0.01% | 383 |
|
|
2022
Q1 | $90K | Hold |
380
| – | – | ﹤0.01% | 389 |
|
|
2021
Q4 | $87K | Hold |
380
| – | – | ﹤0.01% | 402 |
|
|
2021
Q3 | $73K | Sell |
380
-1,090
| -74% | -$221K | ﹤0.01% | 420 |
|
|
2021
Q2 | $313K | Hold |
1,470
| – | – | ﹤0.01% | 265 |
|
|
2021
Q1 | $300K | Sell |
1,470
-864
| -37% | -$170K | ﹤0.01% | 253 |
|
|
2020
Q4 | $425K | Buy |
2,334
+21
| +0.9% | +$3.57K | ﹤0.01% | 224 |
|
|
2020
Q3 | $387K | Sell |
2,313
-336
| -13% | -$56.6K | ﹤0.01% | 215 |
|
|
2020
Q2 | $431K | Buy |
2,649
+30
| +1% | +$5.38K | 0.01% | 191 |
|
|
2020
Q1 | $453K | Buy |
2,619
+130
| +5% | +$25.9K | 0.01% | 182 |
|
|
2019
Q4 | $500K | Hold |
2,489
| – | – | 0.01% | 205 |
|
|
2019
Q3 | $526K | Sell |
2,489
-30
| -1% | -$6.27K | 0.01% | 195 |
|
|
2019
Q2 | $489K | Hold |
2,519
| – | – | 0.01% | 196 |
|
|
2019
Q1 | $415K | Sell |
2,519
-1,931
| -43% | -$341K | 0.01% | 203 |
|
|
2018
Q4 | $837K | Hold |
4,450
| – | – | 0.02% | 158 |
|
|
2018
Q3 | $757K | Hold |
4,450
| – | – | 0.01% | 176 |
|
|
2018
Q2 | $729K | Buy |
4,450
+2,589
| +139% | +$423K | 0.01% | 182 |
|
|
2018
Q1 | $301K | Buy |
1,861
+1,686
| +963% | +$268K | 0.01% | 233 |
|
|
2017
Q4 | $26K | Sell |
175
-17
| -9% | -$2.42K | ﹤0.01% | 488 |
|
|
2017
Q3 | $26K | Buy |
192
+17
| +10% | +$2.15K | ﹤0.01% | 479 |
|
|
2017
Q2 | $21K | Hold |
175
| – | – | ﹤0.01% | 487 |
|
|
2017
Q1 | $21K | Hold |
175
| – | – | ﹤0.01% | 487 |
|
|
2016
Q4 | $20K | Hold |
175
| – | – | ﹤0.01% | 473 |
|
|
2016
Q3 | $18K | Hold |
175
| – | – | ﹤0.01% | 486 |
|
|
2016
Q2 | $17K | Hold |
175
| – | – | ﹤0.01% | 496 |
|
|
2016
Q1 | $17K | Hold |
175
| – | – | ﹤0.01% | 490 |
|
|
2015
Q4 | $16K | Sell |
175
-9,220
| -98% | -$868K | ﹤0.01% | 526 |
|
|
2015
Q3 | $874K | Hold |
9,395
| – | – | 0.02% | 162 |
|
|
2015
Q2 | $874K | Sell |
9,395
-530
| -5% | -$49.4K | 0.02% | 162 |
|
|
2015
Q1 | $940K | Buy |
9,925
+9,750
| +5,571% | +$903K | 0.02% | 161 |
|
|
2014
Q4 | $16K | Hold |
175
| – | – | ﹤0.01% | 518 |
|
|
2014
Q3 | $14K | Hold |
175
| – | – | ﹤0.01% | 504 |
|
|
2014
Q2 | $12K | Hold |
175
| – | – | ﹤0.01% | 544 |
|
|
2014
Q1 | $13K | Hold |
175
| – | – | ﹤0.01% | 522 |
|
|
2013
Q4 | $14K | Hold |
175
| – | – | ﹤0.01% | 501 |
|
|
2013
Q3 | $13K | Hold |
175
| – | – | ﹤0.01% | 471 |
|
|
2013
Q2 | $13K | Buy |
+175
| New | +$11.5K | ﹤0.01% | 511 |
|
Other funds holding CME
Loring Wolcott & Coolidge Fiduciary Advisors's CME Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors held its CME Group (CME) position steady in Q2 2026 at 100 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #484.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CME in Q2 2013 and has held it in 47 quarters since. The position peaked at $940K in Q1 2015. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 100 shares of CME Group worth $22.1K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors left its CME Group share count unchanged in Q2 2026.
- CME Group made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #484 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CME Group in Q2 2013 and has held it in 47 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's CME Group position peaked at $940K in Q1 2015.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.